---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-065686"
form_type: "8-K"
ticker: "PFSA"
cik: "0001859807"
company_name: "Profusa, Inc."
filed_at: "2025-07-18T23:59:59+00:00"
generated_at: "2026-05-18T05:49:43.690533+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# NorthView Acquisition Corp closes merger with Profusa, Inc., becoming Profusa, Inc.

## Summary
- Profusa valued at $155M; exchange ratio of 0.94 shares of new common stock per Profusa share.
- Issued $10M principal PIPE convertible note to Ascent Partners at 10% OID, 18-month maturity.
- Founder shares locked up for 8 months; other lock-up periods from 6 to 12 months.
- Profusa is a clinical-stage digital health company with CE-marked Lumee Oxygen and Lumee Glucose in trials.
- PIPE Investors subject to lock-up and registration rights; security interest granted on assets.

## SEC filing metadata
- accession: 0001213900-25-065686
- form_type: 8-K
- ticker: PFSA
- cik: 0001859807
- company_name: Profusa, Inc.
- filed_at: 2025-07-18T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 3.02, 9.01, 3.03, 5.01, 5.02, 5.06, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859807/000121390025065686/0001213900-25-065686-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859807/000121390025065686/ea0249267-8k_profusa.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-065686
- JSON: https://secwatch.observer/filing/0001213900-25-065686.json
- Plain text: https://secwatch.observer/filing/0001213900-25-065686.txt

## Key facts
- Governance Changes
  Profusa, Inc.: NorthView ceased to be a shell company upon closing of the business combination.
  - Change: shell status
  source text: NorthView ceased to be a shell company upon the Closing.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1859807/000121390025065686/0001213900-25-065686-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.